Intranasal Quetiapine and Hypotension Onset
Hypotension from snorted quetiapine typically develops within 1-4 hours after intranasal administration, with peak effects occurring during the rapid absorption phase.
Timeline of Cardiovascular Effects
When quetiapine is administered intranasally (snorted), the onset of hypotension occurs more rapidly than with oral administration due to bypassed first-pass metabolism and faster systemic absorption. Based on the pharmacodynamics of quetiapine and overdose case reports:
- Initial cardiovascular effects: 1-2 hours post-administration
- Peak hypotensive effects: 2-4 hours post-administration
- Associated tachycardia: Occurs concurrently with hypotension 1, 2, 3, 4
The FDA label for Seroquel indicates that quetiapine induces orthostatic hypotension through α1-adrenergic antagonist properties, with syncope reported in 1% of therapeutic users 1. In overdose scenarios (which intranasal abuse mimics due to rapid absorption), hypotension presents as a prominent feature alongside CNS depression and tachycardia 2, 3, 4.
Clinical Presentation Pattern
The hypotension from quetiapine follows a predictable pattern:
- Early phase (0-2 hours): Onset of dizziness, tachycardia, initial blood pressure changes
- Peak phase (2-4 hours): Maximal hypotensive effect, potential for severe drops requiring intervention
- Duration: Hypotension can persist for 24-48 hours in significant exposures 2, 3
In one documented case of massive quetiapine overdose (20g), hypotension (90/60 mmHg) was present at 4 hours post-ingestion, with a severe hypotensive episode (70/40 mmHg) occurring at 13 hours 2. Another case series showed that patients with quetiapine overdose presented with hypotension requiring ICU admission, with median length of stay of 35 hours 3.
Critical Management Considerations
Intranasal administration accelerates all pharmacodynamic effects compared to oral dosing, making the 1-4 hour window particularly high-risk. The hypotension is mediated by α1-receptor antagonism 5, 6.
Vasopressor Selection is Critical
If hypotension develops and requires vasopressor support, noradrenaline (norepinephrine) is the vasopressor of choice—NOT adrenaline (epinephrine). This is a crucial clinical pitfall 5, 6.
- Adrenaline paradoxically worsens hypotension in quetiapine overdose due to β2-receptor agonism causing vasodilation while α1-receptors remain blocked 6
- Noradrenaline is preferred because it maintains α1-receptor agonism with less β2-receptor affinity 5, 6
- Multiple case reports document dramatic blood pressure drops when adrenaline was used, with restoration of hemodynamic stability only after switching to noradrenaline 6
Monitoring Recommendations
For any patient presenting after intranasal quetiapine use:
- Continuous cardiac monitoring for at least 6-8 hours minimum
- Serial blood pressure measurements every 15-30 minutes during the first 4 hours
- ECG monitoring for QTc prolongation (mean QTc 487ms in overdose cases) and tachycardia 3
- Airway assessment as CNS depression can progress rapidly, with 4 of 18 patients in one series requiring mechanical ventilation 3
The combination of rapid absorption via intranasal route, α1-antagonism, and potential for sudden deterioration makes the first 4 hours post-exposure the highest-risk period for cardiovascular collapse 4.